Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 5, 2011, Pages 1085-1100

  Medeiros, C A C X ^a,b   Leitao R F C ^b   MacEdo, R N ^b   Barboza, D R M M ^b   Gomes, A S ^b   Nogueira, N A P ^b   Alencar, N M N ^b   Ribeiro, R A ^b   Brito, G A C ^b  

^a DEPARTAMENTO DE FÍSICA   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

5 Fluorouracil; Atorvastatin; Oral mucositis; Statin

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; ATORVASTATIN; ATORVASTATINA; CYTOKINE; FLUOROURACIL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRITE; SODIUM CHLORIDE; THIOL GROUP; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTEREMIA; CHEEK MUCOSA; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; EXPERIMENTAL ANIMAL; GRAM NEGATIVE BACTERIUM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LIVER INJURY; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; STOMATITIS; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMETABOLITES, ANTINEOPLASTIC; BACTEREMIA; CRICETINAE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FLUOROURACIL; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOPENIA; MALE; MESOCRICETUS; MOUTH MUCOSA; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PEROXIDASE; PYRROLES; STOMATITIS; SULFHYDRYL COMPOUNDS;

EID: 79955550637     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1409-7     Document Type: Article

References (69)

1. J Clarke R Butler G Howarth L Read G Regester 2002 Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy induced mucositis in the hamster Oral Oncol 38 478 485 12110343 10.1016/S1368-8375(01) 00107-5 1:CAS:528:DC%2BD38XltFags7Y%3D (Pubitemid 34756734)
2. ST Sonis EG Fey 2002 Oral complications of cancer therapy Oncology 16 680 686 12108892
3. JA Jones EB Avritscher CD Cooksley M Michelet BN Bekele LS Elting 2006 Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer Support Care Cancer 14 505 515 16601950 10.1007/s00520-006-0055-4
4. A Trotti LA Bellm JB Epstein D Frame HJ Fuchs CK Gwede, et al. 2003 Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review Radiother Oncol 66 253 262 12742264 10.1016/S0167-8140(02) 00404-8 (Pubitemid 36556043)
5. S Sonis J Clark 1991 Prevention and management of oral mucositis induced by antineoplastic therapy Oncology 5 6 10
6. LS Elting EB Rubenstein KVI Rolston GP Bodey 1997 Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials Clin Infect Dis 25 247 259 9332520 10.1086/514550 1:STN:280:DyaK2svntlKkug%3D%3D (Pubitemid 27364722)
7. C Scully S Sonis PD Diz 2006 Oral mucositis Oral Dis 12 229 241 16700732 10.1111/j.1601-0825.2006.01258.x 1:STN:280:DC%2BD283ntlaluw%3D%3D (Pubitemid 43736412)
8. WJ Köstler M Hejna C Wenzel CC Zielinski 2001 Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment CA Cancer Journal Clin 51 290 315 10.3322/canjclin.51.5.290 (Pubitemid 34232774)
9. N Treister S Sonis 2007 Mucositis: biology and management Current Opinion in Otolaryngology & Head and Neck Surgery 15 123 129 10.1097/MOO. 0b013e3280523ad6 (Pubitemid 46594866)
10. ST Sonis RL Peterson LJ Edwards CA Lucey L Wang L Manson, et al. 2000 Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters Oral Oncol 36 373 381 10899677 10.1016/S1368-8375(00)00012-9 1:CAS:528:DC%2BD3cXkslSit7c%3D (Pubitemid 30427259)
11. ST Sonis 2004 The pathobiology of mucositis Nat Rev Cancer 4 277 284 15057287 10.1038/nrc1318 1:CAS:528:DC%2BD2cXis1Gmt78%3D (Pubitemid 38525283)
12. M Jasiñska J Owczarek D Orszulak-Michalak 2007 Statins: a new insight into their mechanisms of action and consequent pleiotropic effects Pharmacologic Reports 25 483 499
13. PR Hebert JM Gaziano KS Chan CH Hennekens 2007 Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials [review] JAMA 278 313 321 10.1001/jama.278.4.313
14. TR Pedersen 1999 Statin trials and goals of cholesterol-lowering therapy after AMI [review] Am Heart J 138 177 182 10.1016/S0002-8703(99)70340-6 (Pubitemid 29379661)
15. U Laufs V La Fata J Plutzky JK Liao 1998 Up regulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1129 1135 9537338 1:CAS:528:DyaK1cXisVWmsrY%3D (Pubitemid 28152885)
16. U Laufs D Marra K Node JK Liao 1999 3-Hydroxy-3- methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1) J Biol Chem 274 21926 21931 10419514 10.1074/jbc.274.31.21926 1:CAS:528:DyaK1MXltVymtL8%3D (Pubitemid 29360029)
17. M Aikawa E Rabkin S Sugiyama SJ Voglic Y Fukumoto Y Furukawa, et al. 2001 An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro Circulation 103 276 283 11208689 1:CAS:528:DC%2BD3MXhtFaitr4%3D (Pubitemid 32095415)
18. G Huhle C Abletshauser N Mayer G Weidinger J Harenberg DL Heene 1999 Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor Thromb Res 95 229 234 10515287 10.1016/S0049-3848(99)00037-7 1:CAS:528:DyaK1MXmtVGmu7c%3D (Pubitemid 29428154)
19. RS Rosenson AS Brown 2002 Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence Curr Opin Lipidol 13 625 630 12441886 10.1097/00041433-200212000-00005 1:CAS:528:DC%2BD38XoslOqu7k%3D (Pubitemid 36009201)
20. LL Stoll ML McCormick GM Denning NL Weintraub 2004 Antioxidant effects of statins Drugs Today 40 975 990 15645009 10.1358/dot.2004.40.12.872573 1:CAS:528:DC%2BD2MXis1Smtrk%3D (Pubitemid 40128717)
21. PM Ridker N Rifai MA Pfeffer FM Sacks LA Moye S Goldman, et al. 1998 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 839 844 9738637 1:CAS:528:DyaK1cXlvFyhur0%3D (Pubitemid 28397432)
22. C Arnaud V Braunersreuther F Mach 2005 Toward immunomodulatory and anti-inflammatory properties of statins Trends Cardiovasc Med 15 202 206 16182129 10.1016/j.tcm.2005.07.002 1:CAS:528:DC%2BD2MXhtVart7vM (Pubitemid 41338006)
23. M Endres U Laufs 2004 Effects of statins on endothelium and signaling mechanisms Stroke 35 0001 0004 10.1161/01.STR.0000143319.73503.38 (Pubitemid 39458376)
24. I Inoue S Goto K Mizotani T Awata T Mastunaga S Kawa, et al. 2000 Lipophilic HMG-CoA reductase inhibitor has an antiinflammatory effect: reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPAR α) in primary endothelial cells Life Sci 67 863 876 10946846 10.1016/S0024-3205(00)00680-9 1:CAS:528:DC%2BD3cXltlWjtrc%3D (Pubitemid 30491080)
25. G Weitz-Schmidt K Welzenbach V Brinkmann T Kamata J Kallen C Bruns, et al. 2001 Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin Nat Med 7 687 692 11385505 10.1038/89058 1:CAS:528:DC%2BD3MXktlGkurc%3D (Pubitemid 32588024)
26. U Laufs K Gertz P Huang G Nickenig M Bohm U Dirnagl, et al. 2000 Atorvastatin up regulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice Stroke 31 2442 2449 11022078 1:CAS:528: DC%2BD3cXnsVKqtrc%3D
27. RFC Leitão RA Ribeiro EAL Bellaguarda FDB Macedo LR Silva RB Oriá, et al. 2007 Role of nitric oxide on pathogenesis of 5-Fluorouracil induced experimental oral mucositis in hamster Cancer Chemother Pharmacol 59 603 612 16944152 10.1007/s00280-006-0301-y (Pubitemid 46295124)
28. MH Souza LE Troncon FQ Cunha RB Oliveira 2003 Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin- induced gastric damage in rats Braz J Med Biol Res 36 1383 1390 14502371 10.1590/S0100-879X2003001000015 1:STN:280: DC%2BD3svjvFOmuw%3D%3D (Pubitemid 37322268)
29. EA Bayer M Wilchek 1980 The use of the avidin-biotin complex as a tool in molecular biology Meth Biochem Anal 26 1 45 10.1002/9780470110461.ch1 1:CAS:528:DyaL3cXls1eltLg%3D
30. JC Chen HM Chen MH Shyr LL Fan TY Chi CP Chi, et al. 2000 Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine J Formos Med Assoc 99 213 218 10820953 1:CAS:528:DC%2BD3cXjslSltb0%3D
31. J Sedlak RH Lindsay 1968 Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal Biochem 25 192 205 4973948 10.1016/0003-2697(68)90092-4 1:CAS:528:DyaF1MXhslCktA%3D%3D
32. SM Hsu L Raine 1981 Protein A, avidin, and biotin in immunohistochemistry J Histochem Cytochem 29 11 1349 1353 6172466 10.1177/29.11.6172466 1:CAS:528:DyaL38XmsFShtg%3D%3D (Pubitemid 12231851)
33. GEP Souza SH Ferreira 1985 Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity Agents Actions 17 97 103 4083185 10.1007/BF01966691 (Pubitemid 16179303)
34. Murray RR, Baron EJ, Pfaller MA, Tenover FC, Volkers RH (1995) Manual of clinical microbiology. American Society Microbiology, Washington, pp 65-77
35. V Lima GAC Brito FQ Cunha CG Rebouças BAA Falcão RF Augusto, et al. 2005 Effects of the tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters Eur J Oral Sci 113 210 217 15953245 10.1111/j.1600-0722.2005.00216.x 1:CAS:528:DC%2BD2MXms1eisLs%3D (Pubitemid 40880666)
36. AH Wagner M Gebauer B Güldenzoph M Hecker 2002 3-hydroxy-3- methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells Arterioscler Thromb Vasc Biol 22 1784 1789 12426205 10.1161/01.ATV.0000037098.20829.31 1:CAS:528:DC%2BD38Xot1Oitbg%3D (Pubitemid 35315762)
37. U Schönbeck N Gerdes N Varo RS Reynolds DB Horton U Bavendiek, et al. 2002 Oxidized low-density lipoprotein augments and 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells Circulation 106 2888 2893 12460867 10.1161/01.CIR. 0000043029.52803.7B (Pubitemid 35424737)
38. MM Sadeghi A Tiglio K Sadigh L O'Donnell M Collinge R Pardi, et al. 2001 Inhibition of interferon-gamma mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors Transplantation 71 1262 1268 11397960 10.1097/00007890-200105150- 00014 1:CAS:528:DC%2BD3MXks1Clsb8%3D (Pubitemid 32507145)
39. ST Sonis L Lindquist A Van Vugt AA Stewart K Stam GY Qu, et al. 1994 Prevention of chemotherapy induced ulcerative mucositis by transforming growth factor beta-3 Cancer Res 54 1135 1138 8118793 1:CAS:528:DyaK2cXhvVCjtr8%3D (Pubitemid 24108044)
40. ST Sonis LS Elting D Keefe DE Peterson M Schubert M Hauer-Jensen, et al. 2004 Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995 2025 15108222 10.1002/cncr.20162 (Pubitemid 38528741)
41. MM Barsante E Roffe CM Yokoro WL Tafuri DG Souza V Pinho, et al. 2005 Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis Eur J Pharmacol 516 282 289 15970284 10.1016/j.ejphar.2005.05.005 1:CAS:528:DC%2BD2MXlslymtrY%3D (Pubitemid 40922750)
42. YM Sun Y Tian X Li YY Liu LF Wang J Li, et al. 2009 Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia reperfusion injury in rats Biochem Biophys Res Commun 382 336 340 19275881 10.1016/j.bbrc.2009.03.019 1:CAS:528:DC%2BD1MXkt1Sksr4%3D
43. KK Wu 2005 Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators Prostaglandins Leukot Essent Fatty Acids 72 89 93 15626591 10.1016/j.plefa.2004.11.001 1:CAS:528:DC%2BD2MXjvFOg (Pubitemid 40051225)
44. A Planavila JC Laguna M Vazquez-Carrea 2005 Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-Kappa B activation Biochim Biophys Acta 1687 76 83 15708355 1:CAS:528:DC%2BD2MXhtlSrs7o%3D (Pubitemid 40228987)
45. R Prasad S Giri N Nath I Singh AK Singh 2005 Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B) nuclear factor-Kappa B pathway by lovastatin limits endothelial-monocyte cell interaction J Neurochem 94 204 214 15953363 10.1111/j.1471-4159.2005.03182.x 1:CAS:528:DC%2BD2MXlvFCksbc%3D (Pubitemid 40911406)
46. K Kröncke K Fehsel V Kolb-Bachofen 1997 Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide: Biol Chem 2 107 120 10.1006/niox.1997.0118 (Pubitemid 28076552)
47. RP Allaker LSS Mendez JM Hardie N Benjamin 2001 Antimicrobial effect of acidified nitrite on periodontal bacteria Oral Microbiol Immunol 16 253 256 11442852 10.1034/j.1399-302X.2001.160410.x 1:CAS:528:DC%2BD3MXlvVGqurc%3D (Pubitemid 32657016)
48. C Estrada C Gomez C Martin S Moncada C Gonzalez 1992 Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells Biochem Biophys Res Commun 186 475 482 1378728 10.1016/S0006-291X(05)80832-0 1:CAS:528:DyaK38XltV2ku74%3D
49. SH Ralston D Todd MH Helfrich N Benjamin P Grabowski 1994 Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase Endocrinology 135 330 336 7516867 10.1210/en.135.1.330 1:CAS:528:DyaK2cXksl2ntr8%3D (Pubitemid 24203834)
50. M Laurent M Lepoivre J Tenu 1996 Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase Biochem J 314 109 113 8660270 1:CAS:528:DyaK28XhtlKmtrY%3D (Pubitemid 26063839)
51. ZM Lohinai C Szabó 1998 Role of nitric oxide physiology and pathophysiology of periodontal tissues Med Sci Monit 4 1089 1095 1:CAS:528:DyaK1MXitF2hsrc%3D (Pubitemid 29142796)
52. HK Kendall RI Marshall PM Bartold 2001 Nitric oxide and tissue destruction Oral Dis 7 2 10 11354916 10.1034/j.1601-0825.2001.70102.x 1:STN:280:DC%2BD3M3lsFKgsg%3D%3D (Pubitemid 32216850)
53. D Baldassarre B Porta M Camera M Amato M Arquati B Brusoni, et al. 2009 Study group. Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment Nutr Metab Cardiovasc Dis 19 481 490 19171469 10.1016/j.numecd.2008.10.003 1:CAS:528:DC%2BD1MXhtFalu7%2FO
54. RFC Leitão RA Ribeiro MAS Lira LR Silva EAL Bellaguarda FDB Macedo, et al. 2008 Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster Cancer Chemother Pharmacol 61 215 222 17426972 10.1007/s00280-007-0463-2 (Pubitemid 350161768)
55. 1 J Surg Res 111 222 228 12850466 10.1016/S0022-4804(03)00083-0 1:CAS:528:DC%2BD3sXlt1ejsLo%3D (Pubitemid 36808913)
56. R Denno JD Rounds R Faris LB Holejko DW Wilmore 1996 Glutamine-enriched total parenteral nutrition enhances plasma glutathione in the resting state J Surg Res 61 35 38 8769939 10.1006/jsre.1996.0077 1:CAS:528:DyaK28Xhslyls7o%3D (Pubitemid 26066025)
57. RA Karmali 1984 Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione Cancer Biochem Biophys 7 147 154 6432306 1:CAS:528:DyaL2cXlt1altbY%3D (Pubitemid 14087241)
58. BJ Buckley RS Kent AR Whorton 1991 Regulation of endothelial cell prostaglandin synthesis by glutathione J Biol Chem 266 16659 16666 1885596 1:CAS:528:DyaK3MXlslGrtr8%3D (Pubitemid 21907850)
59. DD Waters 2005 Safety of high-dose atorvastatin therapy Am J Cardiol 96 69F 75F 16126026 10.1016/j.amjcard.2005.06.028 1:CAS:528:DC%2BD2MXhtVGgtr7K (Pubitemid 41207736)
60. A Nakad L Bataille V Hamoir C Sempoux Y Horsmans 1999 Atorvastatin- induced acute hepatitis with absence of cross-toxicity with simvastatin Lancet 353 1763 1764 10347994 10.1016/S0140-6736(99)00569-3 1:STN:280: DyaK1M3nsFOmsg%3D%3D (Pubitemid 29240380)
61. E Ridruejo OG Mando 2002 Acute cholestatic hepatitis after reinitiating treatment with atorvastatin J Hepatol 37 165 166 12076881 10.1016/S0168-8278(02) 00092-2 (Pubitemid 34713073)
62. K Keyomarsi L Sandoval V Band AB Pardee 1991 Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin Cancer Res 51 3602 3609 1711413 1:CAS:528:DyaK3MXksVWmsLY%3D
63. KK Chan AM Oza LL Siu 2003 The statins as anticancer agents Clin Cancer Res 9 10 19 12538446 1:CAS:528:DC%2BD3sXnt1OnsQ%3D%3D (Pubitemid 36109711)
64. MF Demierre PD Higgins SB Gruber E Hawk SM Lippman 2005 Statins and cancer prevention Nat Rev Cancer 5 930 942 16341084 10.1038/nrc1751 1:CAS:528:DC%2BD2MXht1ykurbL (Pubitemid 41766782)
65. MUR Naidu GV Ramana PU Rani IK Mohan A Suman P Roy 2004 Chemotherapy-induced and or radiation therapy-induced oral mucositis- complicating the treatment of cancer. Review article Neoplasia 6 423 431 15548350 10.1593/neo.04169 (Pubitemid 39411078)
66. CC McGown ZLS Brookes 2007 Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide Br J Anaesth 98 163 175 17251210 10.1093/bja/ael358 1:CAS:528:DC%2BD2sXivF2lurY%3D (Pubitemid 47071995)
67. Y Almog 2003 Statins, Inflammation and Sepsis Chest 124 740 743 12907568 10.1378/chest.124.2.740 1:CAS:528:DC%2BD3sXnt12rsLY%3D (Pubitemid 37000158)
68. MW Merx EA Liehn U Janssens R Lütticken J Schrader P Hanrath, et al. 2004 HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis Circulation 109 2560 2565 15123521 10.1161/01.CIR. 0000129774.09737.5B 1:CAS:528:DC%2BD2cXkt1ars70%3D (Pubitemid 38720557)
69. P Kruger K Fitzsimmons D Cook M Jones G Nimmo, et al. 2006 Statin therapy is associated with fewer deaths in patients with bacteraemia Intensive Care Med 32 75 79 16283159 10.1007/s00134-005-2859-y (Pubitemid 43039379)